Cala Health, a pioneering force in bioelectronic medicine, has successfully secured $50 million in funding to further its mission of revolutionizing chronic disease management through innovative wearable neuromodulation therapies. Based in the San Francisco Bay Area, Cala Health is at the forefront of merging advanced neuroscience with cutting-edge technology to provide personalized peripheral nerve stimulation for patients suffering from essential tremor, a debilitating condition affecting over seven million individuals worldwide. This recent funding will not only bolster the production and distribution of Cala Health’s first wearable therapy designed for essential tremor but also accelerate the development of new therapies across various medical fields, including neurology, cardiology, and psychiatry. With robust backing from leading investors in healthcare and technology, Cala Health aims to set a new standard in patient care – one where individualized and non-invasive treatments can help improve the quality of life for millions. As we raise awareness this Essential Tremor Awareness Month, this funding marks a significant step forward in empowering patients with innovative solutions that address their unique health challenges. Stay tuned for updates on how Cala Health continues to lead the charge in transforming chronic disease management and enhancing patient outcomes through technology!








